NSG
PHAR

Nalls Sherbakoff Group’s Pharming Group PHAR Stock Holding History

Nalls Sherbakoff Group’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Hold
870
– – 0.01% 268
2026
Q1 		$14.5K Hold
870
– – 0.01% 282
2025
Q4 		$15.4K Hold
870
– – 0.01% 297
2025
Q3 		$12.6K Hold
870
– – 0.01% 312
2025
Q2 		$9.3K Hold
870
– – 0.01% 331
2025
Q1 		$7.28K Buy
+870
New +$7.8K 0.01% 312

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Nalls Sherbakoff Group's PHAR Position: Q2 2026 in Review

Nalls Sherbakoff Group held its Pharming Group (PHAR) position steady in Q2 2026 at 870 shares worth $12.1K. The position accounts for 0.01% of the portfolio, ranked #268.

Nalls Sherbakoff Group first reported a position in PHAR in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.4K in Q4 2025. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Nalls Sherbakoff Group held 870 shares of Pharming Group worth $12.1K as of Q2 2026.
  • Nalls Sherbakoff Group left its Pharming Group share count unchanged in Q2 2026.
  • Pharming Group made up 0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #268 holding.
  • Nalls Sherbakoff Group first reported a position in Pharming Group in Q1 2025 and has held it in 6 quarters since.
  • Nalls Sherbakoff Group's Pharming Group position peaked at $15.4K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.